Information about the stopping of the medicinal product Vermox oral suspension 100 mg/5ml (mebendazol) production
22.03.2013
KRKA-FARMA d.o.o., the marketing authorisation holder for the medicinal product Vermox suspension 100 mg/5 ml (mebendazole) has informed the Agency for Medicinal Products and Medical Devices about the production stopping of the product.
There is no other authorised medicinal product for the same indication in Croatia. There is a possibility of a substitution therapy import under the legal exemption scheme for patients who need treatment with this product.
